Ciro E.
- Country
- Italy
- Department
- Unità di Nefrologia, Dialisi e Trapianto
Research Overview
- A Phase 2 Study to Evaluate the Safety and Tolerability of ADX-038 in Participants With Complement-Mediated Kidney Disease
- Effect of Zigakibart on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adults with IgA Nephropathy: An Open-Label Study
- Efficacy and Safety of Oral BI 764198 in Adults and Adolescents with Primary or TRPC6-Variant Genetic Focal Segmental Glomerulosclerosis: A Randomized, Placebo-Controlled Trial
- Istituti Clinici Scientifici Maugeri S.p.A. Societa' Benefit In Forma Abbreviata Istituti Clinici Scientifici Maugeri S.p.A. Sb O Anche Ics Maugeri S.p.A. Sb O Maugeri S.p.A. Sb
- Fondazione Salvatore Maugeri Clinica Del Lavoro E Della Riabilitazione
- Istituti Clinici Scientifici Maugeri S.p.A. Societa' Benefit In Forma Abbreviata Istituti Clinici Scientifici Maugeri S.p.A. Sb O Anche Ics Maugeri S.p.A. Sb O Maugeri S.p.A. Sb
Data & Insights
Has run more than one trial at 294 of 708 partner sites.
Specializations
Glomerular Diseases
The investigator specializes in treating various forms of glomerulonephritis, with particular emphasis on IgA nephropathy and focal segmental glomerulosclerosis. Their research explores innovative therapeutic approaches for these conditions, including targeted therapies based on kidney biopsy findings.
- Primary IgA Nephropathy Management
- Focal Segmental Glomerulosclerosis Treatment
- Membranous Nephropathy Interventions
The investigator evaluates novel therapeutic agents targeting specific pathways in glomerular diseases.
Chronic Kidney Disease
Focuses on comprehensive management of chronic kidney disease, including innovative approaches to slow disease progression and treat associated complications. Investigates various therapeutic agents for reducing proteinuria and preserving renal function.
- CKD Progression Management
- Albuminuria Reduction Strategies
- Renal Function Preservation
Expertise includes evaluation of combination therapies and novel compounds for CKD treatment.
Renal Complications
Specializes in managing complex renal conditions including anemia in chronic kidney disease and cardiovascular complications in patients with end-stage kidney disease. Investigates targeted treatments for specific patient populations.
- Dialysis-Related Complications
- Renal Anemia Management
- Cardiovascular Risk in ESKD
Evaluates therapeutic approaches for managing multiple aspects of kidney disease complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.